Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.31 trillion and total revenue of $115.29 billion.
Market Cap
1.31T
Revenue
115.29B
Profits
-39.02B
PE Ratio
n/a
Profit Margin
-33.84%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 133.25B | -0.74% | 1,047,017 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.68B | 0.12% | 575,164 | 15.53B |
| 3 | ARGX | argenx SE | 54.93B | 1.30% | 172,618 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 43.99B | -0.14% | 1,175,945 | - |
| 5 | ONC | BeOne Medicines AG | 40.82B | -0.06% | 314,913 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 34.05B | 2.47% | 3,924,340 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.97B | 1.24% | 1,621,305 | 4.80B |
| 8 | INSM | Insmed Incorporated | 28.89B | -0.22% | 1,563,224 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.12B | 2.58% | 4,993,056 | 7.53M |
| 10 | MRNA | Moderna, Inc. | 25.42B | 5.12% | 6,581,997 | 2.23B |
| 11 | INCY | Incyte Corporation | 24.48B | -0.25% | 1,055,268 | 5.82B |
| 12 | BNTX | BioNTech SE | 23.30B | -0.06% | 476,504 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.77B | 1.85% | 3,516,974 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.84B | 0.35% | 440,054 | 1.20B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.39B | 0.17% | 2,793,620 | 713.07M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 16.16B | 0.39% | 553,512 | 4.60B |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.60B | 0.99% | 2,840,874 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 12.48B | -1.85% | 2,938,705 | 2.44B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.39B | 0.17% | 285,551 | 1.28B |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.32B | -2.23% | 1,119,664 | 669.50M |
| 21 | CORT | Corcept Therapeutics Incorporated | 12.13B | 0.29% | 662,995 | 830.81M |
| 22 | SMMT | Summit Therapeutics Inc. | 12.05B | -0.13% | 3,676,479 | - |
| 23 | HALO | Halozyme Therapeutics, Inc. | 11.55B | -0.81% | 3,650,586 | 1.66B |
| 24 | TECH | Bio-Techne Corporation | 11.26B | 0.11% | 2,359,005 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 11.24B | -0.51% | 1,240,601 | 776.57M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.87B | -1.02% | 525,367 | 5.67M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 10.79B | 4.22% | 500,043 | 7.46M |
| 28 | CYTK | Cytokinetics, Incorporated | 10.52B | -1.06% | 2,105,583 | 67.67M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.15B | -0.10% | 802,272 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 9.85B | 1.78% | 161,952 | 440.48M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.84B | 2.51% | 417,204 | 281.99M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.48B | 4.02% | 961,008 | 105.00M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.39B | 2.00% | 1,999,668 | 874.09M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.18B | 1.31% | 909,634 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.96B | 0.12% | 2,583,863 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.88B | 0.73% | 1,220,579 | - |
| 37 | IMVT | Immunovant, Inc. | 8.80B | 4.08% | 2,002,380 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.20B | 1.84% | 5,340,412 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.10B | 4.21% | 574,307 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 7.11B | 2.60% | 945,326 | - |
| 41 | BLTE | Belite Bio, Inc | 7.04B | 0.77% | 156,369 | - |
| 42 | TGTX | TG Therapeutics, Inc. | 7.02B | -0.80% | 2,017,944 | 799.54M |
| 43 | CGON | CG Oncology, Inc. | 6.82B | -0.05% | 766,130 | 6.23M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.77B | 0.72% | 2,977,684 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.55B | 3.36% | 899,250 | - |
| 46 | ERAS | Erasca, Inc. | 6.50B | 1.47% | 3,647,531 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 6.43B | 0.75% | 649,574 | 618.07M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 6.32B | 3.23% | 778,193 | 7.50M |
| 49 | CAI | Caris Life Sciences, Inc. | 6.29B | -3.80% | 4,024,675 | 989.61M |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 6.29B | 3.61% | 654,003 | 1.90M |
| 51 | PTCT | PTC Therapeutics, Inc. | 6.06B | -1.44% | 976,043 | 1.01B |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.86B | 3.24% | 1,041,006 | 591.33M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.85B | 1.57% | 380,029 | 290.54M |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.75B | 4.60% | 7,635,641 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 5.22B | -0.15% | 742,905 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.07B | 0.14% | 1,409,740 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.89B | -2.02% | 1,781,369 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.76B | 2.58% | 217,345 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.73B | -1.69% | 995,786 | - |
| 60 | MANE | Veradermics, Incorporated | 4.56B | 0.09% | 1,359,695 | - |
| 61 | CELC | Celcuity Inc. | 4.49B | 4.51% | 795,242 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.40B | 0.40% | 1,610,990 | 10.35M |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.31B | -2.89% | 2,433,849 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -1.46% | 1,010,952 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 4.17B | -0.25% | 76,441 | 803.79M |
| 66 | DNLI | Denali Therapeutics Inc. | 4.04B | 2.35% | 1,442,379 | 3.60M |
| 67 | LEGN | Legend Biotech Corporation | 3.99B | -5.41% | 3,689,539 | 1.27B |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.97B | 0.65% | 1,473,686 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.84B | 3.41% | 1,509,461 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.69B | 0.77% | 943,851 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.57B | 0.33% | 508,832 | 234.13M |
| 72 | CLDX | Celldex Therapeutics, Inc. | 3.52B | 1.22% | 1,594,599 | 158.00K |
| 73 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.76% | 1,627,511 | 7.12M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | 0.19% | 1,184,073 | 463.98M |
| 75 | ALMS | Alumis Inc. | 3.26B | 0.71% | 991,904 | 8.40M |
| 76 | MBX | MBX Biosciences, Inc. | 3.23B | 1.45% | 331,488 | - |
| 77 | IMNM | Immunome, Inc. | 3.18B | 6.63% | 1,561,641 | 4.02M |
| 78 | ABCL | AbCellera Biologics Inc. | 3.17B | 6.10% | 14,854,539 | 66.17M |
| 79 | QURE | uniQure N.V. | 3.13B | 0.29% | 737,520 | 18.67M |
| 80 | IRON | Disc Medicine, Inc. | 3.09B | -0.76% | 263,481 | - |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 3.07B | 0.80% | 1,017,403 | 606.33M |
| 82 | IOVA | Iovance Biotherapeutics, Inc. | 3.05B | 3.85% | 13,458,734 | 324.97M |
| 83 | ZLAB | Zai Lab Limited | 2.86B | -1.96% | 2,182,417 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.76B | 2.58% | 912,788 | 36.77M |
| 85 | KOD | Kodiak Sciences Inc. | 2.71B | 3.09% | 382,971 | - |
| 86 | ATAI | AtaiBeckley Inc. | 2.68B | 0.28% | 3,865,814 | 4.47M |
| 87 | BEAM | Beam Therapeutics Inc. | 2.67B | -0.52% | 1,554,142 | 156.04M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.37% | 1,545,158 | 717.00M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.59B | -0.39% | 1,578,318 | 71.13M |
| 90 | NKTR | Nektar Therapeutics | 2.57B | 0.70% | 542,901 | 55.63M |
| 91 | PHVS | Pharvaris N.V. | 2.56B | 5.93% | 1,273,193 | - |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.53B | -0.39% | 1,226,987 | - |
| 93 | COAG | Hemab Therapeutics Holdings, Inc. | 2.50B | 3.36% | 278,466 | - |
| 94 | PGEN | Precigen, Inc. | 2.45B | -0.15% | 4,424,090 | 85.72M |
| 95 | KLRA | Kailera Therapeutics, Inc. | 2.41B | -1.48% | 246,474 | - |
| 96 | URGN | UroGen Pharma Ltd. | 2.40B | 4.01% | 1,581,533 | 188.73M |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -1.02% | 1,396,598 | - |
| 98 | SLS | SELLAS Life Sciences Group, Inc. | 2.38B | 6.52% | 7,796,833 | - |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.32B | 0.63% | 693,498 | 959.90M |
| 100 | VCEL | Vericel Corporation | 2.29B | 0.86% | 290,767 | 306.30M |
| 101 | RAPP | Rapport Therapeutics, Inc. | 2.29B | -2.23% | 316,898 | 20.00M |
| 102 | NUVB | Nuvation Bio Inc. | 2.25B | 0.78% | 2,592,652 | 169.90M |
| 103 | SEPN | Septerna, Inc. | 2.25B | 0.90% | 1,261,317 | 98.88M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 2.25B | 4.82% | 4,006,398 | 52.06M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 0.50% | 166,682 | - |
| 106 | ADMA | ADMA Biologics, Inc. | 2.19B | -1.31% | 1,919,177 | 512.28M |
| 107 | MESO | Mesoblast Limited | 2.19B | -0.83% | 211,811 | 65.38M |
| 108 | BHVN | Biohaven Ltd. | 2.17B | -0.69% | 2,139,033 | - |
| 109 | VERA | Vera Therapeutics, Inc. | 2.16B | -0.99% | 1,676,575 | - |
| 110 | STOK | Stoke Therapeutics, Inc. | 2.13B | 0.03% | 977,978 | 27.59M |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 2.09B | -4.12% | 3,913,789 | 5.49M |
| 112 | GHRS | GH Research PLC | 2.08B | 3.99% | 1,133,476 | - |
| 113 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.52% | 854,448 | 311.51M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | 4.65% | 1,223,094 | 98.34M |
| 115 | KARD | Kardigan, Inc. | 2.04B | -1.27% | 243,553 | - |
| 116 | NBTX | Nanobiotix S.A. | 2.02B | 1.86% | 180,530 | 38.27M |
| 117 | ZBIO | Zenas BioPharma, Inc. | 1.98B | -3.55% | 461,597 | 1.00M |
| 118 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | 0.88% | 2,369,422 | 1.97B |
| 119 | GENB | Generate Biomedicines, Inc. | 1.94B | 5.75% | 750,303 | 26.48M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.91B | 2.11% | 314,351 | - |
| 121 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.12% | 1,924,025 | - |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -2.78% | 376,504 | 1.13B |
| 123 | IMCR | Immunocore Holdings plc | 1.79B | 1.64% | 352,958 | 430.78M |
| 124 | ZYME | Zymeworks Inc. | 1.77B | 2.51% | 563,640 | 37.13M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -2.41% | 1,069,456 | 252.25M |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -1.79% | 10,305,060 | 54.86M |
| 127 | FTRE | Fortrea Holdings Inc. | 1.74B | -6.10% | 1,664,754 | 2.68B |
| 128 | AAPG | Ascentage Pharma Group International | 1.74B | -0.05% | 2,625 | 82.08M |
| 129 | XNCR | Xencor, Inc. | 1.72B | 4.89% | 1,967,663 | 104.97M |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 0.58% | 2,041,978 | 59.51M |
| 131 | ANAB | AnaptysBio, Inc. | 1.69B | -1.54% | 381,729 | 232.39M |
| 132 | BRVE | Braveheart Bio, Inc. | 1.68B | 4.56% | 634,096 | - |
| 133 | AVLN | Avalyn Pharma Inc. | 1.66B | 5.41% | 378,238 | - |
| 134 | ABSI | Absci Corporation | 1.63B | 0.96% | 4,040,439 | 1.56M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.63B | 3.66% | 810,300 | - |
| 136 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | -1.33% | 407,049 | - |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.53B | 0.81% | 441,662 | 20.00M |
| 138 | VIR | Vir Biotechnology, Inc. | 1.52B | 0.34% | 984,213 | 303.23M |
| 139 | TYRA | Tyra Biosciences, Inc. | 1.51B | 0.48% | 478,347 | - |
| 140 | INVA | Innoviva, Inc. | 1.50B | 0.29% | 595,870 | 440.00M |
| 141 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.50B | -0.52% | 1,739,327 | 208.78M |
| 142 | JBIO | Jade Biosciences, Inc. | 1.48B | 3.85% | 713,873 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.47B | 3.86% | 2,913,600 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 0.22% | 295,752 | - |
| 145 | LBRX | LB Pharmaceuticals Inc | 1.46B | 0.11% | 355,992 | - |
| 146 | SVRA | Savara Inc. | 1.45B | 2.33% | 1,175,072 | - |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.44B | 6.47% | 158,559 | 1.30M |
| 148 | REPL | Replimune Group, Inc. | 1.43B | 11.65% | 8,272,476 | - |
| 149 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 0.15% | 1,147,120 | - |
| 150 | GLUE | Monte Rosa Therapeutics, Inc. | 1.36B | 1.21% | 780,929 | 28.73M |
| 151 | IMTX | Immatics N.V. | 1.33B | -0.41% | 188,425 | 43.00M |
| 152 | AKTS | Aktis Oncology, Inc. | 1.33B | -3.11% | 213,795 | 8.28M |
| 153 | VOR | Vor Biopharma Inc. | 1.32B | -5.30% | 992,203 | - |
| 154 | NVAX | Novavax, Inc. | 1.31B | 0.13% | 2,541,803 | 413.80M |
| 155 | DRTS | Alpha Tau Medical Ltd. | 1.28B | -2.80% | 500,609 | - |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.27B | 1.88% | 246,294 | - |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 2.17% | 1,025,098 | - |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | -0.15% | 675,991 | - |
| 159 | MNKD | MannKind Corporation | 1.24B | 0.26% | 3,055,998 | 393.63M |
| 160 | LTGO | Latigo Biotherapeutics, Inc. | 1.23B | 4.62% | 208,210 | - |
| 161 | OBX | Obsidian Therapeutics, Inc. | 1.21B | -14.89% | 111,535 | - |
| 162 | MGTX | MeiraGTx Holdings plc | 1.20B | -0.69% | 274,581 | 79.76M |
| 163 | EYPT | EyePoint, Inc. | 1.17B | 3.68% | 2,261,369 | 2.79M |
| 164 | ANRO | Alto Neuroscience, Inc. | 1.13B | 1.39% | 278,064 | - |
| 165 | SANA | Sana Biotechnology, Inc. | 1.13B | -0.53% | 1,819,577 | - |
| 166 | IVA | Inventiva S.A. | 1.12B | -0.85% | 414,801 | 7.94M |
| 167 | APMD | Apnimed, Inc. | 1.06B | 7.14% | 273,834 | 120.15M |
| 168 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 0.41% | 317,250 | 59.00K |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -3.29% | 2,569,148 | 41.47M |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 6.04% | 89,503 | 99.00K |
| 171 | WVE | Wave Life Sciences Ltd. | 1.03B | 3.76% | 5,205,183 | 65.37M |
| 172 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.91% | 652,909 | 24.00M |
| 173 | ANNX | Annexon, Inc. | 1.01B | -0.19% | 3,950,407 | - |
| 174 | GERN | Geron Corporation | 1.01B | -3.68% | 10,202,343 | 204.56M |
| 175 | OMER | Omeros Corporation | 992.27M | 0.81% | 3,583,213 | 38.42M |
| 176 | ARDX | Ardelyx, Inc. | 989.27M | 0.76% | 4,954,858 | 450.89M |
| 177 | SLDB | Solid Biosciences Inc. | 972.00M | 2.43% | 744,824 | - |
| 178 | DSGN | Design Therapeutics, Inc. | 917.45M | 0.27% | 465,709 | - |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | 913.48M | 0.10% | 1,301,556 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 908.12M | -1.71% | 1,399,245 | 181.72M |
| 181 | KURA | Kura Oncology, Inc. | 882.42M | 0.10% | 1,147,141 | 77.23M |
| 182 | TBPH | Theravance Biopharma, Inc. | 878.47M | - | 495,211 | 104.31M |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 859.64M | -1.35% | 937,109 | 8.22M |
| 184 | SGP | SpyGlass Pharma, Inc. | 845.23M | 1.69% | 76,852 | - |
| 185 | DBVT | DBV Technologies S.A. | 833.37M | 0.35% | 146,744 | 5.04M |
| 186 | CLYM | Climb Bio, Inc. | 826.51M | 3.90% | 1,318,672 | - |
| 187 | PHAR | Pharming Group N.V. | 820.19M | -3.27% | 38,282 | 366.48M |
| 188 | IMMX | Immix Biopharma, Inc. | 813.40M | -1.04% | 1,549,058 | - |
| 189 | AURA | Aura Biosciences, Inc. | 803.71M | -3.61% | 901,979 | - |
| 190 | OCS | Oculis Holding AG | 795.73M | 1.10% | 253,153 | 1.45M |
| 191 | DRUG | Bright Minds Biosciences Inc. | 787.36M | -1.10% | 108,218 | - |
| 192 | CADL | Candel Therapeutics, Inc. | 782.53M | 0.28% | 1,378,941 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 782.13M | -0.36% | 335,546 | 276.79M |
| 194 | ATTO | Attovia Therapeutics, Inc. | 777.10M | -3.16% | 603,876 | 1.35M |
| 195 | MNPR | Monopar Therapeutics Inc. | 771.23M | 0.38% | 354,198 | - |
| 196 | CTMX | CytomX Therapeutics, Inc. | 760.47M | 1.16% | 2,519,272 | 18.30M |
| 197 | FTH | Faeth Therapeutics, Inc. | 759.19M | -2.07% | 284,227 | - |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 754.61M | 2.39% | 150,524 | - |
| 199 | STTK | Shattuck Labs, Inc. | 751.72M | 4.32% | 1,286,908 | 1.00M |
| 200 | NGNE | Neurogene Inc. | 740.02M | 3.30% | 342,640 | 925.00K |
| 201 | PHAT | Phathom Pharmaceuticals, Inc. | 728.37M | 7.76% | 2,084,117 | 239.66M |
| 202 | RGNX | REGENXBIO Inc. | 720.20M | 2.44% | 877,342 | 174.48M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 720.00M | 15.56% | 665,622 | - |
| 204 | ALLO | Allogene Therapeutics, Inc. | 715.17M | -2.36% | 4,577,716 | 4.64M |
| 205 | HELP | Cybin Inc. | 712.20M | 13.88% | 3,237,441 | - |
| 206 | GYRE | Gyre Therapeutics, Inc. | 706.18M | 0.30% | 94,546 | 109.82M |
| 207 | CBIO | Crescent Biopharma, Inc. | 703.22M | -1.56% | 214,715 | 11.88M |
| 208 | AGMB | AgomAb Therapeutics NV | 694.89M | -4.98% | 151,421 | - |
| 209 | ACHV | Achieve Life Sciences, Inc. | 688.42M | -1.18% | 1,407,749 | - |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 679.35M | 0.88% | 708,532 | 136.07M |
| 211 | SLN | Silence Therapeutics plc | 641.44M | -7.74% | 5,443,587 | 615.00K |
| 212 | NVCT | Nuvectis Pharma, Inc. | 636.64M | 0.67% | 78,896 | - |
| 213 | VSTM | Verastem, Inc. | 629.42M | -1.42% | 1,263,817 | 87.53M |
| 214 | MDXG | MiMedx Group, Inc. | 623.85M | -0.93% | 729,380 | 355.17M |
| 215 | FDMT | 4D Molecular Therapeutics, Inc. | 620.52M | 3.49% | 430,296 | 88.24M |
| 216 | SPRY | ARS Pharmaceuticals, Inc. | 600.78M | 1.68% | 1,314,030 | 98.99M |
| 217 | PRLD | Prelude Therapeutics Incorporated | 590.16M | 7.71% | 623,877 | 22.42M |
| 218 | SGMT | Sagimet Biosciences Inc. | 583.67M | -1.37% | 1,096,390 | - |
| 219 | ARVN | Arvinas, Inc. | 579.98M | -1.33% | 524,458 | 316.70M |
| 220 | ALT | Altimmune, Inc. | 569.94M | -2.33% | 6,045,806 | 31.00K |
| 221 | PRME | Prime Medicine, Inc. | 569.29M | -1.84% | 1,444,189 | 4.07M |
| 222 | AUTL | Autolus Therapeutics plc | 564.22M | -9.01% | 4,059,387 | 117.39M |
| 223 | EIKN | Eikon Therapeutics, Inc. | 564.12M | 1.86% | 371,294 | - |
| 224 | ARTV | Artiva Biotherapeutics, Inc. | 563.70M | -2.12% | 275,201 | 251.00K |
| 225 | CTNM | Contineum Therapeutics, Inc. | 563.56M | 1.08% | 1,000,715 | - |
| 226 | CRMD | CorMedix Inc. | 557.01M | -2.74% | 1,353,419 | 400.05M |
| 227 | ZURA | Zura Bio Limited | 553.89M | 3.96% | 1,219,106 | - |
| 228 | VALN | Valneva SE | 538.47M | -0.72% | 76,043 | 163.30M |
| 229 | ANL | Adlai Nortye Ltd. | 523.60M | 0.08% | 125,316 | 5.00M |
| 230 | ASMB | Assembly Biosciences, Inc. | 520.93M | -0.77% | 113,072 | 71.10M |
| 231 | MPLT | MapLight Therapeutics, Inc. | 516.03M | -5.01% | 478,524 | - |
| 232 | EVMN | Evommune, Inc. | 512.44M | -0.63% | 694,641 | 10.00M |
| 233 | RLMD | Relmada Therapeutics, Inc. | 503.48M | 5.59% | 1,663,026 | - |
| 234 | BLSM | BlossomHill Therapeutics, Inc. | 497.65M | -1.69% | 424,259 | - |
| 235 | OABI | OmniAb, Inc. | 497.24M | 1.18% | 794,029 | 38.46M |
| 236 | RZLT | Rezolute, Inc. | 490.99M | 1.73% | 2,391,287 | - |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 489.40M | 0.37% | 1,031,485 | - |
| 238 | OVID | Ovid Therapeutics Inc. | 489.00M | 1.55% | 931,468 | 7.12M |
| 239 | DNA | Ginkgo Bioworks Holdings, Inc. | 485.52M | -3.99% | 1,064,661 | 132.42M |
| 240 | ENTX | Entera Bio Ltd. | 484.80M | -6.67% | 410,048 | 42.00K |
| 241 | CCCC | C4 Therapeutics, Inc. | 479.80M | 0.78% | 1,956,862 | 35.04M |
| 242 | PRTA | Prothena Corporation plc | 475.38M | 0.43% | 274,927 | 54.53M |
| 243 | OCGN | Ocugen, Inc. | 474.75M | 2.19% | 3,182,829 | 4.58M |
| 244 | CABA | Cabaletta Bio, Inc. | 464.71M | 2.15% | 2,806,527 | - |
| 245 | PBYI | Puma Biotechnology, Inc. | 459.42M | 1.48% | 372,144 | 231.24M |
| 246 | QTTB | Q32 Bio Inc. | 457.56M | -0.26% | 270,077 | 53.74M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 456.15M | 1.39% | 1,180,764 | - |
| 248 | PROK | ProKidney Corp. | 447.44M | -8.07% | 2,428,995 | 818.00K |
| 249 | IKT | Inhibikase Therapeutics, Inc. | 436.98M | -2.04% | 296,948 | 1.00 |
| 250 | EDIT | Editas Medicine, Inc. | 436.17M | -3.73% | 1,629,923 | 47.01M |
| 251 | SCTX | Scribe Therapeutics Inc. | 434.07M | -1.83% | 77,310 | 36.28M |
| 252 | SLBT | SL Science Holding Limited | 431.54M | - | 117,193 | 3.27M |
| 253 | CMPX | Compass Therapeutics, Inc. | 426.81M | 7.73% | 8,291,258 | 850.00K |
| 254 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.59M | -3.28% | 220,929 | - |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 425.34M | 0.23% | 1,041,028 | 15.85M |
| 256 | ABEO | Abeona Therapeutics Inc. | 425.18M | 0.81% | 2,213,064 | 14.54M |
| 257 | BNTC | Benitec Biopharma Inc. | 423.93M | -8.46% | 1,268,634 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 414.45M | -7.43% | 358,943 | 59.22M |
| 259 | AVIR | Atea Pharmaceuticals, Inc. | 404.94M | 0.20% | 292,193 | - |
| 260 | LXEO | Lexeo Therapeutics, Inc. | 399.55M | 1.88% | 1,630,274 | - |
| 261 | VTVT | vTv Therapeutics Inc. | 394.86M | -3.81% | 50,545 | 36.84M |
| 262 | FHTX | Foghorn Therapeutics Inc. | 394.32M | 0.76% | 235,979 | 36.74M |
| 263 | ENTA | Enanta Pharmaceuticals, Inc. | 393.19M | -0.15% | 149,824 | 65.26M |
| 264 | UPB | Upstream Bio, Inc. | 378.47M | -2.54% | 635,221 | 3.16M |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 374.33M | -2.57% | 954,048 | - |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 368.85M | -0.44% | 140,045 | - |
| 267 | IPSC | Century Therapeutics, Inc. | 354.91M | -4.85% | 530,613 | 109.16M |
| 268 | STRO | Sutro Biopharma, Inc. | 353.18M | -14.94% | 1,434,244 | 45.70M |
| 269 | LYEL | Lyell Immunopharma, Inc. | 347.24M | -4.77% | 98,146 | 27.00K |
| 270 | VCRE | Vicore Pharma Holding AB (publ) | 346.17M | 6.55% | 6,020 | 370.61K |
| 271 | SABS | SAB Biotherapeutics, Inc. | 345.75M | 1.06% | 307,682 | 114.70K |
| 272 | CUVL | Clinuvel Pharmaceuticals Limited | 342.16M | -2.62% | 2,337 | 64.24M |
| 273 | PALI | Palisade Bio, Inc. | 341.57M | -8.41% | 2,376,604 | 500.00K |
| 274 | IMRX | Immuneering Corporation | 328.02M | 5.63% | 902,995 | - |
| 275 | FATE | Fate Therapeutics, Inc. | 317.04M | -0.73% | 1,230,020 | 6.32M |
| 276 | NMRA | Neumora Therapeutics, Inc. | 316.84M | 0.59% | 351,606 | - |
| 277 | AVXL | Anavex Life Sciences Corp. | 316.01M | -2.85% | 667,079 | - |
| 278 | TTRX | Turn Therapeutics Inc. | 313.97M | 3.13% | 68,774 | - |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 313.80M | 5.27% | 1,076,326 | 215.72M |
| 280 | IRD | Opus Genetics, Inc. | 312.82M | -3.09% | 480,423 | 9.86M |
| 281 | AGEN | Agenus Inc. | 310.64M | 1.02% | 1,154,187 | 132.69M |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 307.47M | 4.38% | 559,030 | 26.87M |
| 283 | IFRX | InflaRx N.V. | 296.21M | 0.50% | 1,570,168 | -11.54K |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 291.43M | 0.53% | 796,310 | - |
| 285 | SRZN | Surrozen, Inc. | 284.32M | -3.43% | 271,495 | 11.51M |
| 286 | BCYC | Bicycle Therapeutics plc | 284.17M | -1.46% | 639,925 | 61.21M |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 283.83M | 0.81% | 901,396 | 80.00M |
| 288 | SION | Sionna Therapeutics, Inc. | 282.58M | 22.55% | 9,438,014 | - |
| 289 | LCTX | Lineage Cell Therapeutics, Inc. | 278.20M | -1.79% | 698,007 | 13.08M |
| 290 | ALXO | ALX Oncology Holdings Inc. | 277.94M | 4.15% | 2,419,813 | - |
| 291 | TRDA | Entrada Therapeutics, Inc. | 276.56M | 8.95% | 263,660 | 4.69M |
| 292 | WHWK | Whitehawk Therapeutics, Inc. | 268.51M | 0.86% | 310,893 | 7.15M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 265.66M | 0.45% | 207,748 | 31.98M |
| 294 | PRQR | ProQR Therapeutics N.V. | 262.49M | -3.12% | 422,404 | 15.73M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 262.47M | 0.99% | 74,750 | 1.48M |
| 296 | ACIU | AC Immune SA | 260.50M | 3.15% | 380,457 | 21.67M |
| 297 | MGNX | MacroGenics, Inc. | 255.52M | 2.55% | 339,282 | 157.08M |
| 298 | GLSI | Greenwich LifeSciences, Inc. | 248.36M | 8.81% | 200,444 | - |
| 299 | ADAG | Adagene Inc. | 247.77M | -3.60% | 294,444 | 9.29M |
| 300 | CAPR | Capricor Therapeutics, Inc. | 242.65M | 6.62% | 2,752,847 | 11.13M |
| 301 | NAGE | Niagen Bioscience, Inc. | 242.64M | -0.65% | 395,187 | 129.08M |
| 302 | ALEC | Alector, Inc. | 240.06M | 2.87% | 786,197 | 13.86M |
| 303 | ANTX | AN2 Therapeutics, Inc. | 236.98M | 6.98% | 429,197 | - |
| 304 | CGEN | Compugen Ltd. | 236.81M | 4.17% | 447,015 | 74.00M |
| 305 | IPHA | Innate Pharma S.A. | 235.24M | 14.88% | 385,306 | 10.57M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 235.22M | 8.63% | 493,137 | 3.93M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 233.73M | -8.24% | 52,302 | 18.47M |
| 308 | TARA | Protara Therapeutics, Inc. | 229.88M | -0.51% | 467,688 | - |
| 309 | CLLS | Cellectis S.A. | 223.20M | 1.73% | 12,430 | 63.82M |
| 310 | KROS | Keros Therapeutics, Inc. | 222.06M | 5.26% | 159,710 | 15.01M |
| 311 | IMUX | Immunic, Inc. | 216.99M | 2.91% | 299,382 | - |
| 312 | NBP | NovaBridge Biosciences | 216.26M | 1.63% | 217,012 | - |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.02M | 1.06% | 422,595 | 29.37M |
| 314 | IVVD | Invivyd, Inc. | 215.65M | 6.47% | 1,685,479 | 55.87M |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 211.10M | 7.82% | 2,012,469 | 80.62M |
| 316 | RNA | Atrium Therapeutics, Inc. | 208.18M | -0.81% | 84,175 | 36.68M |
| 317 | GALT | Galectin Therapeutics Inc. | 206.79M | 0.32% | 231,492 | - |
| 318 | MSLE | Satellos Bioscience Inc. | 206.66M | - | 3,469 | - |
| 319 | OTLK | Outlook Therapeutics, Inc. | 205.70M | -2.65% | 8,070,070 | 333.14K |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 205.30M | -3.00% | 468,545 | 29.10M |
| 321 | DTIL | Precision BioSciences, Inc. | 204.80M | -1.20% | 268,143 | 45.06M |
| 322 | PYXS | Pyxis Oncology, Inc. | 201.47M | 12.37% | 1,935,639 | 13.86M |
| 323 | PEPG | PepGen Inc. | 200.85M | - | 768,009 | - |
| 324 | VYGR | Voyager Therapeutics, Inc. | 197.18M | - | 376,087 | 34.46M |
| 325 | KRRO | Korro Bio, Inc. | 196.59M | 0.23% | 95,412 | 2.38M |
| 326 | CNXU | Conexeu Sciences Inc. | 195.60M | -1.75% | 140,531 | - |
| 327 | ACOG | Alpha Cognition Inc. | 194.88M | 0.67% | 76,002 | 10.83M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 188.77M | 2.63% | 551,800 | - |
| 329 | NGEN | NervGen Pharma Corp. | 187.29M | 1.15% | 387,017 | - |
| 330 | NERV | Minerva Neurosciences, Inc. | 187.17M | -9.26% | 138,335 | - |
| 331 | YDES | YD Bio Limited | 182.83M | -4.76% | 22,049 | 510.36K |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 181.51M | 1.62% | 487,164 | - |
| 333 | VOGX | Vogenx, Inc. | 180.93M | - | 683,982 | - |
| 334 | CHRS | Coherus Oncology, Inc. | 180.77M | -3.31% | 1,155,915 | 50.94M |
| 335 | HUMA | Humacyte, Inc. | 179.31M | -6.34% | 11,169,105 | 2.12M |
| 336 | MDWD | MediWound Ltd. | 178.77M | -0.14% | 50,188 | 14.48M |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 177.62M | 0.47% | 162,887 | 2.00M |
| 338 | CDXS | Codexis, Inc. | 175.21M | 8.11% | 1,612,483 | 77.68M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 171.20M | 1.62% | 2,136,102 | 1.34M |
| 340 | NKTX | Nkarta, Inc. | 171.18M | 2.58% | 629,101 | - |
| 341 | CRBU | Caribou Biosciences, Inc. | 168.61M | 0.59% | 717,444 | 11.20M |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 160.25M | 1.41% | 126,489 | 5.54M |
| 343 | OKUR | OnKure Therapeutics, Inc. | 159.15M | -3.91% | 54,482 | - |
| 344 | LENZ | LENZ Therapeutics, Inc. | 158.36M | -3.26% | 2,139,016 | 21.48M |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 153.06M | -11.42% | 5,785,635 | 2.34M |
| 346 | CNTN | Canton Strategic Holdings, Inc. | 151.93M | 3.68% | 317,854 | - |
| 347 | MENS | Jyong Biotech Ltd. | 151.44M | -2.86% | 32,561 | - |
| 348 | MOLN | Molecular Partners AG | 150.64M | - | - | 856.30K |
| 349 | UNCY | Unicycive Therapeutics, Inc. | 150.14M | 7.80% | 1,511,195 | - |
| 350 | HURA | TuHURA Biosciences, Inc. | 149.02M | 1.74% | 646,505 | - |
| 351 | CNTB | Connect Biopharma Holdings Limited | 146.71M | 4.02% | 371,986 | 2.95M |
| 352 | KZIA | Kazia Therapeutics Limited | 146.15M | -7.85% | 256,667 | 1.27M |
| 353 | CBUS | Cibus, Inc. | 144.27M | -0.53% | 90,942 | 4.29M |
| 354 | AARD | Aardvark Therapeutics, Inc. | 143.78M | -8.62% | 158,604 | - |
| 355 | NRXP | NRx Pharmaceuticals, Inc. | 140.82M | -1.18% | 927,899 | 2.29M |
| 356 | EQ | Equillium, Inc. | 137.83M | -2.24% | 600,086 | 4.39M |
| 357 | SPRB | Spruce Biosciences, Inc. | 135.28M | 1.42% | 26,254 | 697.00K |
| 358 | PMN | ProMIS Neurosciences, Inc. | 130.03M | -3.14% | 12,827 | - |
| 359 | TLSA | Tiziana Life Sciences Ltd | 128.01M | -1.98% | 2,047,672 | - |
| 360 | CUE | Cue Biopharma, Inc. | 127.77M | 7.72% | 180,737 | 32.73M |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 120.65M | 0.48% | 645,617 | 70.00M |
| 362 | GNLX | Genelux Corporation | 119.90M | 1.89% | 250,836 | 8.00K |
| 363 | YARW | Yarrow Bioscience, Inc. | 119.76M | -0.40% | 11,185 | - |
| 364 | SEER | Seer, Inc. | 118.38M | -0.93% | 515,092 | 14.22M |
| 365 | VANI | Vivani Medical, Inc. | 118.14M | -1.44% | 155,365 | - |
| 366 | INDP | Indaptus Therapeutics, Inc. | 115.51M | -14.29% | 276,328 | - |
| 367 | NAUT | Nautilus Biotechnology, Inc. | 114.49M | 1.00% | 608,529 | 190.00K |
| 368 | ENGN | enGene Therapeutics Inc. | 113.88M | -6.59% | 1,670,501 | - |
| 369 | GUTS | Fractyl Health, Inc. | 110.42M | -0.83% | 545,022 | 3.00K |
| 370 | COYA | Coya Therapeutics, Inc. | 110.01M | -2.29% | 85,589 | 8.02M |
| 371 | ANIX | Anixa Biosciences, Inc. | 109.89M | 0.31% | 145,306 | - |
| 372 | RANI | Rani Therapeutics Holdings, Inc. | 109.47M | 2.27% | 539,080 | 3.17M |
| 373 | PLYX | Polaryx Therapeutics, Inc. | 105.58M | 1.36% | 44,147 | - |
| 374 | PTHS | Pelthos Therapeutics Inc. | 100.48M | 0.98% | 23,512 | 27.70M |
| 375 | ICCC | ImmuCell Corporation | 99.33M | 0.27% | 26,829 | 29.93M |
| 376 | CGTX | Cognition Therapeutics, Inc. | 98.90M | 1.96% | 821,257 | - |
| 377 | TENX | Tenax Therapeutics, Inc. | 98.52M | 6.17% | 12,540,865 | - |
| 378 | ONCY | Oncolytics Biotech Inc. | 98.31M | 0.45% | 716,016 | - |
| 379 | PYPD | PolyPid Ltd. | 98.31M | 2.33% | 265,406 | - |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 93.74M | -0.76% | 62,195 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 92.78M | -0.78% | 248,642 | - |
| 382 | ALDX | Aldeyra Therapeutics, Inc. | 91.70M | 0.66% | 939,365 | - |
| 383 | FBIO | Fortress Biotech, Inc. | 91.35M | 5.36% | 1,007,763 | 66.16M |
| 384 | GANX | Gain Therapeutics, Inc. | 90.43M | 2.91% | 586,876 | - |
| 385 | NTHI | NeOnc Technologies Holdings, Inc. | 89.73M | -20.46% | 1,105,288 | 39.99K |
| 386 | ACET | Adicet Bio, Inc. | 88.91M | 0.36% | 39,850 | - |
| 387 | RLYB | Rallybio Corporation | 88.10M | 1.28% | 17,666 | 646.00K |
| 388 | VRCA | Verrica Pharmaceuticals Inc. | 87.44M | -2.49% | 26,921 | 30.32M |
| 389 | GOSS | Gossamer Bio, Inc. | 86.82M | -2.31% | 5,333,493 | 55.54M |
| 390 | INO | Inovio Pharmaceuticals, Inc. | 84.42M | 0.55% | 3,142,480 | 65.34K |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.91M | - | 179,641 | - |
| 392 | ATRA | Atara Biotherapeutics, Inc. | 83.12M | 3.19% | 90,000 | 6.19M |
| 393 | ATHE | Alterity Therapeutics Limited | 82.33M | 4.47% | 26,036 | 4.43M |
| 394 | OKYO | OKYO Pharma Limited | 78.98M | -0.99% | 14,486 | - |
| 395 | NRXS | NeurAxis, Inc. | 77.65M | -1.26% | 152,145 | 5.32M |
| 396 | ANVS | Annovis Bio, Inc. | 76.58M | -4.76% | 502,308 | - |
| 397 | TELO | Telomir Pharmaceuticals, Inc. | 76.34M | -1.77% | 52,591 | - |
| 398 | XBIT | XBiotech Inc. | 75.00M | 5.58% | 58,617 | - |
| 399 | LONA | LeonaBio, Inc. | 73.93M | 3.28% | 3,488 | - |
| 400 | ELOX | Eloxx Pharmaceuticals, Inc. | 73.72M | -4.77% | 45,154 | - |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 73.62M | -0.58% | 152,064 | - |
| 402 | IBIO | iBio, Inc. | 73.03M | - | 599,651 | 300.00K |
| 403 | ELTX | Elicio Therapeutics, Inc. | 71.76M | 0.99% | 140,618 | - |
| 404 | OSTX | OS Therapies Incorporated | 71.71M | 0.63% | 225,071 | - |
| 405 | CING | Cingulate Inc. | 70.17M | 0.19% | 85,396 | - |
| 406 | SPRO | Spero Therapeutics, Inc. | 68.90M | -3.25% | 774,554 | 47.00M |
| 407 | RNTX | Rein Therapeutics Inc. | 68.86M | -1.46% | 79,858 | - |
| 408 | CSBR | Champions Oncology, Inc. | 68.77M | -0.80% | 5,679 | 59.43M |
| 409 | IMA | ImageneBio, Inc. | 68.00M | 6.77% | 9,290 | 800.00K |
| 410 | CRDF | Cardiff Oncology, Inc. | 67.72M | -5.67% | 1,288,176 | 508.00K |
| 411 | BSEM | BioStem Technologies, Inc. | 67.36M | 5.26% | 160,128 | 91.15M |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 67.20M | -3.08% | 208,344 | - |
| 413 | PLRX | Pliant Therapeutics, Inc. | 66.25M | 3.88% | 913,694 | - |
| 414 | MNOV | MediciNova, Inc. | 65.46M | 0.76% | 13,117 | 596.64K |
| 415 | DWTX | Dogwood Therapeutics, Inc. | 64.74M | 4.62% | 58,369 | - |
| 416 | HRTX | Heron Therapeutics, Inc. | 64.72M | 5.28% | 3,588,688 | 151.18M |
| 417 | BOLD | Boundless Bio, Inc. | 63.24M | 1.09% | 252,608 | - |
| 418 | HYFT | MindWalk Holdings Corp. | 61.55M | -5.07% | 122,505 | 11.43M |
| 419 | ALPS | Alps Group Inc | 59.57M | -11.60% | 108,345 | 3.74M |
| 420 | INMB | INmune Bio Inc. | 56.62M | -1.92% | 352,101 | 50.00K |
| 421 | INKT | MiNK Therapeutics, Inc. | 56.59M | 1.16% | 4,718 | - |
| 422 | IMMP | Immutep Limited | 54.22M | -2.59% | 142,604 | 5.28M |
| 423 | XLO | Xilio Therapeutics, Inc. | 54.14M | -1.42% | 9,312 | 64.09M |
| 424 | ATYR | aTyr Pharma, Inc. | 53.00M | 1.18% | 331,528 | 190.00K |
| 425 | EXOZ | eXoZymes, Inc. | 52.48M | - | 2,284 | -700.00 |
| 426 | EDSA | Edesa Biotech, Inc. | 51.06M | -3.99% | 26,306 | - |
| 427 | TIL | Instil Bio, Inc. | 50.73M | -0.13% | 3,805 | - |
| 428 | TCRX | TScan Therapeutics, Inc. | 50.52M | -0.49% | 527,969 | 7.11M |
| 429 | RNXT | RenovoRx, Inc. | 50.51M | -2.61% | 477,074 | 1.98M |
| 430 | MREO | Mereo BioPharma Group plc | 48.35M | -0.85% | 8,484,540 | 500.00K |
| 431 | IBO | Impact BioMedical Inc. | 48.20M | 3.95% | 14,421 | 35.00K |
| 432 | VRXA | Veraxa Biotech AG | 47.66M | - | 40,345 | - |
| 433 | MCRB | Seres Therapeutics, Inc. | 46.92M | 1.72% | 45,372 | 1.88M |
| 434 | CRVO | CervoMed Inc. | 46.42M | -0.65% | 237,782 | 331.30K |
| 435 | KPTI | Karyopharm Therapeutics Inc. | 46.01M | -3.33% | 1,836,839 | 151.12M |
| 436 | MGX | Metagenomi Therapeutics, Inc. | 45.93M | 0.83% | 91,289 | 13.56M |
| 437 | FLNA | Filana Therapeutics, Inc. | 45.09M | -3.94% | 247,098 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 44.18M | -0.94% | 121,837 | - |
| 439 | VERU | Veru Inc. | 43.98M | -1.79% | 199,643 | 16.89M |
| 440 | ALGS | Aligos Therapeutics, Inc. | 43.71M | -3.85% | 190,606 | 31.52M |
| 441 | CNTX | Context Therapeutics Inc. | 43.17M | 0.88% | 1,360,085 | - |
| 442 | SER | Serina Therapeutics, Inc. | 42.29M | 1.44% | 108,601 | 130.00K |
| 443 | HYPD | Hyperion DeFi, Inc. | 40.77M | 1.89% | 123,113 | 1.04M |
| 444 | APLM | Apollomics, Inc. | 37.46M | -6.06% | 11,332 | 8.84M |
| 445 | NTRB | Nutriband Inc. | 37.38M | -3.30% | 1,785 | 1.80M |
| 446 | RADX | Radiopharm Theranostics Limited | 36.83M | -2.80% | 28,074 | 10.86M |
| 447 | LTRN | Lantern Pharma Inc. | 33.94M | -4.32% | 122,879 | - |
| 448 | DYAI | Dyadic International, Inc. | 32.07M | -16.19% | 429,312 | 3.80M |
| 449 | ESLA | Estrella Immunopharma, Inc. | 31.85M | 4.96% | 8,649 | - |
| 450 | LITS | Lite Strategy, Inc. | 31.35M | 2.25% | 30,909 | - |
| 451 | NNVC | NanoViricides, Inc. | 31.21M | 0.74% | 241,740 | - |
| 452 | GNTA | Genenta Science S.p.A. | 30.67M | - | 38,421 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 30.57M | -4.49% | 44,135 | - |
| 454 | BYSI | BeyondSpring Inc. | 30.51M | -6.08% | 33,008 | 1.88M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.62M | -1.16% | 59,437 | - |
| 456 | ENLV | Enlivex Ltd. | 29.57M | -4.17% | 644,014 | - |
| 457 | NXTC | NextCure, Inc. | 29.51M | 21.40% | 493,352 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.74M | 0.42% | 4,229 | 7.44M |
| 459 | IGC | IGC Pharma, Inc. | 28.62M | 1.74% | 1,693,942 | 1.11M |
| 460 | TVGN | Tevogen Inc. | 27.30M | -2.71% | 12,302 | - |
| 461 | CVM | CEL-SCI Corporation | 25.87M | -2.63% | 152,982 | - |
| 462 | ATNM | Actinium Pharmaceuticals, Inc. | 25.82M | 3.53% | 240,646 | 35.09M |
| 463 | EVAX | Evaxion A/S | 25.60M | 0.33% | 21,475 | 7.53M |
| 464 | CNSY | Cerenome, Inc. | 25.47M | -3.39% | 65,901 | 5.18M |
| 465 | ABVC | ABVC BioPharma, Inc. | 24.26M | -2.53% | 282,222 | 797.92K |
| 466 | BRNS | Barinthus Biotherapeutics plc | 23.79M | 1.25% | 11,108 | 14.97M |
| 467 | LGVN | Longeveron Inc. | 23.60M | 7.92% | 922,858 | 1.19M |
| 468 | GRDX | GridAI Technologies Corp. | 23.30M | 4.44% | 181,687 | - |
| 469 | ACTU | Actuate Therapeutics, Inc. | 23.21M | -3.97% | 206,518 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 23.08M | -7.75% | 653,426 | - |
| 471 | ALLR | Allarity Therapeutics, Inc. | 22.28M | -2.10% | 65,764 | 345.00K |
| 472 | QNTM | Quantum BioPharma Ltd. | 22.06M | -1.97% | 152,095 | - |
| 473 | COCP | Cocrystal Pharma, Inc. | 21.57M | 3.70% | 51,355 | 225.00K |
| 474 | DARE | Daré Bioscience, Inc. | 21.57M | - | 95,045 | 1.16M |
| 475 | CTXR | Citius Pharmaceuticals, Inc. | 21.00M | 6.25% | 700,741 | 5.61M |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.78M | -1.52% | 27,992 | - |
| 477 | NEUP | Neuphoria Therapeutics Inc. | 20.59M | - | 33,774 | -13.27K |
| 478 | ATOS | Atossa Therapeutics, Inc. | 20.24M | -0.42% | 31,349 | - |
| 479 | CELU | Celularity Inc. | 19.97M | -1.46% | 16,419 | 26.55M |
| 480 | MRKR | Marker Therapeutics, Inc. | 19.34M | 3.57% | 73,068 | 3.55M |
| 481 | TPST | Tempest Therapeutics, Inc. | 19.34M | 2.54% | 388,478 | - |
| 482 | SKYE | Skye Bioscience, Inc. | 19.29M | 1.48% | 76,495 | - |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 18.56M | -0.47% | 452,210 | 21.00M |
| 484 | PLRZ | Polyrizon Ltd. | 18.19M | -4.61% | 34,181 | - |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 18.06M | 9.80% | 102,693 | 1.90M |
| 486 | NCEL | NewcelX Ltd. | 17.93M | 4.39% | 2,673 | - |
| 487 | PLUR | Pluri Inc. | 17.53M | -7.14% | 14,607 | 1.08M |
| 488 | NRSN | NeuroSense Therapeutics Ltd. | 17.33M | -1.20% | 155,254 | - |
| 489 | LPCN | Lipocine Inc. | 16.98M | -1.44% | 48,969 | 1.57M |
| 490 | TVRD | Tvardi Therapeutics, Inc. | 16.60M | - | 98,745 | - |
| 491 | KALA | KALA BIO, Inc. | 16.43M | 4.63% | 62,840 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 16.37M | 2.70% | 140,199 | - |
| 493 | HIND | Vyome Holdings, Inc. | 15.58M | -1.33% | 11,495 | 129.73K |
| 494 | MLEC | Moolec Science SA | 15.19M | 3.11% | 3,726 | 7.83M |
| 495 | PASG | Passage Bio, Inc. | 14.72M | 2.00% | 6,168 | - |
| 496 | PTN | Palatin Technologies, Inc. | 14.66M | 27.80% | 180,235 | 12.88M |
| 497 | CMMB | Chemomab Therapeutics Ltd. | 13.82M | 1.05% | 33,462 | - |
| 498 | ICU | SeaStar Medical Holding Corporation | 13.51M | -8.94% | 159,215 | 1.71M |
| 499 | PDSB | PDS Biotechnology Corporation | 13.51M | -5.76% | 7,116,928 | - |
| 500 | BLRX | BioLineRx Ltd. | 13.18M | -3.06% | 11,292 | 1.40M |